Around this time last week, I was set to post about the Tour de France, praising the fact that not one rider in the field tested positive for performance-enhancing drugs. One week later, thanks to the unavailability of Wi-Fi in Disney World, my post will be much less celebratory.
It was hyped as the most epic Tour ever, with the winners of the last 10 runnings in the field. And while it wasn’t as “epic” as its billing, the 22 days of racing through France unfolded without the doping monster that has so plagued the sport in recent years rearing its ugly head.
That is until last week, when it was revealed that Mikel Astarloza, winner of Stage 16 and 11th overall, tested positive for recombinant erythropoietin (EPO) in an out-of-competition test in June. Continue reading